Sino Biological Advances AI-Designed Molecule Validation with 4RISE™

Faster Expression. Deeper Validation. Integrated Support.

HOUSTON, Nov. 10, 2026 /PRNewswire/ -- AI rapidly generates protein candidates, but experimental validation remains essential to assess expression, target binding, and biological properties. Sino Biological, Inc. (Shenzhen Stock Exchange: 301047.SZ), a global leader in recombinant protein technology, offers 4RISE™, an integrated wet-lab solution combining high-throughput expression, extensive target protein resources, and comprehensive validation. Built on Rapid, In-Depth, Seamless, and Empirical capabilities, 4RISE™ advance AI-designed molecules from computational predictions to experimental evidence.